霍奇金淋巴瘤患者及幸存者的癌症相关疲劳:对治疗结局和社会再融入的影响
研究纳入德国霍奇金研究组第五代临床试验(HD13、HD14、HD15)中提供健康相关生活质量数据的4529例患者,分析严重疲劳(sFA,EORTC QLQ-C30评分≥50)对治疗结局和社会再融入的影响。基线sFA比例为37%,随访期间为20%至24%。基线sFA与无进展生存受损显著相关,总生存有受损趋势;sFA与幸存者就业显著负相关,并伴随经济问题和就医次数增加。
要点
- 基线sFA比例为37%,随访期间为20%至24%。
- 基线sFA与无进展生存受损显著相关,总生存有受损趋势。
- 治疗后5年,有sFA的女性幸存者51%在工作或接受职业教育,男性63%,分别低于无sFA者的78%和90%。
核心结论
- sFA是随访期间阻碍幸存者社会再融入的重要因素。
- 该观察强调在治疗癌症患者及幸存者时,应将疲劳作为重要诊断加以处理。
研究设计与样本
- 研究纳入德国霍奇金研究组第五代临床试验(HD13、HD14、HD15)中5306例患者,排除不合格及年龄>60岁患者后,4529例提供健康相关生活质量数据。
- sFA定义为欧洲癌症研究与治疗组织生活质量问卷核心30(EORTC QLQ-C30)0至100分制中评分≥50。
- 描述治疗前及治疗后长达9年的sFA,并分析其对治疗结局和社会再融入的影响。
主要发现
- 报告sFA的患者比例在基线为37%,随访期间为20%至24%。
- 基线sFA与无进展生存显著受损相关,与总生存有受损趋势,但在接受第五代试验中所用的高效霍奇金淋巴瘤治疗的患者中可被克服。
- 治疗后5年,有sFA的女性幸存者中51%在工作或接受职业教育,男性幸存者中63%在工作或接受职业教育;无sFA者分别为78%和90%(P < .001,校正年龄、性别、分期、基线就业状态和治疗结局)。
- sFA还与经济问题及看全科医生和专科医生的次数相关。
临床怎么用
- 作者认为,治疗癌症患者及幸存者时应将疲劳作为重要诊断加以处理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose Cancer-related fatigue occurs frequently in patients with Hodgkin lymphoma (HL) and has a major impact on their quality of life. We hypothesized that severe fatigue (sFA) might have an impact on patients' treatment outcome and social reintegration. Methods Of 5,306 patients enrolled in the German Hodgkin Study Group's fifth generation of clinical trials in HL (HD13, HD14, and HD15; nonqualified and older [> 60 years] patients excluded), 4,529 provided data on health-related quality of life. We describe sFA (defined as a score ≥ 50 on the 0 to 100 scale from the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30) before and up to 9 years after therapy and analyze its impact on treatment outcome and social reintegration. Results The proportion of patients reporting sFA was 37% at baseline and ranged from 20% to 24% during follow-up. Baseline sFA was associated with significantly impaired progression-free survival and a trend to impaired overall survival, which can be overcome in patients receiving highly effective HL therapies as applied in our fifth-generation trials. Our analysis revealed a significant negative association of sFA and employment in survivors: 5 years after therapy, 51% and 63% of female and male survivors, respectively, with sFA were working or in professional education, compared with 78% and 90% without sFA, respectively ( P < .001 adjusted for age, sex, stage, baseline employment status, and treatment outcome). sFA was also associated with financial problems and the number of visits to a general practitioner and medical specialists. Conclusion sFA is an important factor preventing survivors from social reintegration during follow-up. This observation underscores the need to address fatigue as a significant diagnosis when treating patients with and survivors of cancer.
引用
- Behringer K, Goergen H, Müller H, et al. Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration. J Clin Oncol. 2016. PMID: 27998235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。